AlphAIAlphAI — Financial news for AI agents
stocktitan.net$OMDA

1.1 million people are in Omada Health's virtual care programs, up 36%

Omada Health reported Q3 2026 revenue of $91M, up 34% YoY, with 1.1M members, a 36% increase. Net income was $7M, reversing a $3M loss from Q3 2025. The company raised its full-year 2026 revenue outlook to $344M-$346M and adjusted EBITDA to $32M-$34M.

Original reporting
stocktitan.net
Published Nov 5, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$OMDA
Bullish
high confidence
Mentioned
$OMDA
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$OMDABullishHigh
01

Why it matters

The raised guidance and profit swing could drive short‑term price appreciation.

02

Market read

First‑report earnings with raised guidance; actionable for traders.

03

What to watch

Potential regulatory scrutiny of digital health reimbursements could temper growth.

Relevance 7/10Novelty 8/10Timing: today, pre‑market

Background

Omada Health is a Nasdaq‑listed virtual care provider reporting its Q3 2026 earnings and FY guidance.

Company-level read

Ticker impact

$OMDABullishHigh confidence
Context

Q3 2026 results: $91M revenue, $7M net income and FY2026 revenue guidance raised to $344‑$346M.

Expected impact

likely upside as market prices in higher revenue outlook

Evidence & confidence

Revenue and earnings beat prior year and guidance lifted ~3% YoY, prompting buying interest.

Market effects

Sector

virtual health and digital therapeutics sector may see broader optimism.

Regional

U.S. healthcare investors likely to react.

Global

Limited to companies with similar digital care models.

Counterpoint

What could challenge this read

Guidance may be overly optimistic given competitive pressures and margin sustainability.

Key entities

  • company
    Omada Health, Inc.

    Nasdaq‑listed virtual care provider.

Read at source← All news

Related articles

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

finance.yahoo.com
$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.

finance.yahoo.com
$OMDAMed

Omada Health Reports Third Quarter 2026 Results

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Third Quarter 2026 Results • Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 million • Revenue Grew 34% and Total Members Increased 36% Year over Year • Raises Full Year 2026 Financial Outlook SAN FRANCISCO - November 5, 2026 - Omada H

SEC EDGAR 8-K
$OMDALowAI 8/10

Omada Health reports weight loss study results for GLP-1 program

Omada Health (NASDAQ:OMDA) presented a 12-week study at the World Obesity and Weight Management Congress, showing its GLP-1 Care Track program led to 6.0% average weight loss vs. 3.3% for usual care. The study, published in Diabetes, Obesity and Metabolism, involved 245 adults with obesity. Omada's program also improved body composition, well-being, and reduced depression/anxiety symptoms.

investing.com